New york: A newly emerged strain of the influenza A(H3N2) virus, identified as H32N subclade K, is spreading across multiple regions, raising concerns among global health experts. There is apprehension that this could lead to a more severe flu season, especially affecting older adults and young children.
According to Anadolu Agency, the emergence of the H32N subclade K comes after the 2025-2026 flu vaccine formulation was finalized, leading to concerns about the vaccine's efficacy against the new strain. The mutated virus has undergone significant antigenic drift and has accumulated approximately ten new mutations in its hemagglutinin gene, as reported by the US Centers for Disease Control and Prevention (CDC). Health officials worldwide are closely monitoring the situation as cases continue to rise.
The H3N2 subclade K strain has been linked to early and intense flu activity in several countries. Japan declared an influenza epidemic in early October, and the UK is bracing for a challenging winter with flu cases expected to triple compared to the previous year. Canada has reported early waves of influenza associated with the new strain, while the Southern Hemisphere has seen a 29% rise in severe acute respiratory infections, prompting calls for strengthened preparedness.
In the United States, while flu activity remains typical in timing, the new strain is rapidly becoming dominant. According to the CDC's FluView report for the week ending December 6, H3N2 viruses accounted for 86% of influenza A cases, with about 89% belonging to subclade K. Health experts warn that H3N2-dominated seasons have historically been associated with higher hospitalizations and deaths, particularly among seniors and young children.
The CDC estimates that this flu season has already resulted in 2.9 million illnesses, 30,000 hospitalizations, and 1,200 deaths in the US. Separate reports by CBS News indicate 4.6 million cases and 1,900 related deaths, including at least three children. Dr. Amanda Kravitz from Weill Cornell Medicine highlights the seriousness of this flu season, noting the higher-than-expected number of cases.
The effectiveness of the current flu vaccine against the H3N2 subclade K is a concern, given the emergence of the strain after the vaccine strains were selected. Although a partial mismatch is possible, early data from the UK suggests that the vaccine still provides meaningful protection, with effectiveness rates between 72% and 75% against emergency department visits in children and 32% to 39% in adults. Despite these challenges, CDC officials continue to recommend vaccination.
Vaccination rates have declined this season, adding to the concerns. CDC data shows a nearly 7% drop in flu vaccinations compared to the previous year, attributed in part to a 43-day US government shutdown that limited public access to flu data during peak vaccination weeks.
Symptoms associated with the H3N2 strain can be intense and fast-onset, including high fever, severe body aches, cough, and rapid spread within households and communities. Medical professionals advise seeking medical care if high fevers persist beyond four to five days, especially in children.
Experts emphasize a layered approach to combating the flu season, including vaccination, early testing and antiviral treatment, and maintaining respiratory hygiene. The World Health Organization (WHO) maintains that there is no current sign of increased disease severity, but surveillance continues.
Meanwhile, experts are also monitoring avian influenza following a rare human case of H5N5 in Washington state and new cases reported in South Korea. Authorities have implemented special quarantine measures and increased monitoring to prevent further spread.
With the fast-evolving virus, declining vaccination rates, and early global warning signs, health experts stress the importance of preparedness, surveillance, and early care in determining the severity of this flu season.